Catalent Inc (CTLT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873

Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.

Data as of 2021-07-25 17:16:27 -0400
Market Cap19.804 Billion Shares Outstanding170.342 Million Avg 30-day Volume639.079 Thousand
P/E Ratio39.81486 Dividend Yield0.0 EPS2.96
Price/Sales4.95 Debt to Equity2.15 EBITDA868.8 Million
Price to Book Value4.57 Forward PE Enterprise Value20.757 Billion
Total Cash1.063 Billion Current Debt1.139 Billion Gross Profit1.247 Billion
BETA0.99884 52-week High/Low127.68 / 79.65 Next Earnings Date2021-08-30 Price to Cash FLow (P/CF) 79.5972
Data provided by IEX Cloud
View SEC Filings from CTLT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 8 -62.5% 1 (0.06%) 4 (0.23%) -75.0%
Funds Holding: 482 496 -2.82% 112 (6.57%) 117 (6.79%) -4.27%
13F shares: 165.13 Million 166.574 Million -0.87% 33.073 Million 33.44 Million -1.1%
% Ownership 97.006 19.4286 20.304 -4.31%
New Positions: 57 97 -41.24% 16 22 -27.27%
Increased Positions 197 197 0.0% 45 52 -13.46%
Closed Positions 67 40 67.5% 21 23 -8.7%
Reduced Positions 175 169 3.55% 42 41 2.44%
Total Calls 386.976 Thousand 243.43 Thousand 58.97% 170.7 Thousand 52.8 Thousand 223.3%
Total Puts 483.085 Thousand 257.746 Thousand 87.43% 158.55 Thousand 169.5 Thousand -6.46%
PUT/CALL Ratio 1.25 1.06 17.92% 0.93 3.21 -71.03%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CTLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTLT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

25 Thousand total shares from 15 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GENNADIOS ARISTIPPOS PRESIDENT SOFTGEL & ORAL TECH

  • Officer
56,314 2021-07-26 4

CHIMINSKI JOHN R CHAIR & CEO

  • Officer
  • Director
254,107 2021-07-26 6

FASMAN STEVEN L SVP & GENERAL COUNSEL

  • Officer
78,291 2021-07-26 7

MASELLI ALESSANDRO PRESIDENT & COO

  • Officer
37,202 2021-07-26 3

GUNTHER SCOTT SVP, QUALITY & REG. AFFAIRS

  • Officer
20,075 2021-07-26 5

ARNOLD JONATHAN PRES. ORAL & SPECIALTY DELIV.

  • Officer
43,946 2021-07-26 5

SCHMIDT KAY A SVP, TECHNICAL OPERATIONS

  • Officer
18,783 2021-07-26 7

PRAVDA RICARDO SVP & CHIEF HR OFFICER

  • Officer
16,076 2021-07-26 5

GRIPPO MICHAEL J SVP, STRATEGY & CORP. DEV.

  • Officer
22,616 2021-07-26 6

FLYNN KAREN PRES. BIOLOGICS & CCO

  • Officer
41,648 2021-07-26 3

WHITLOW RICCI S PRESIDENT, CSS

  • Officer
5,855 2021-07-26 3

HOPSON RICKY VP, CHIEF ACCOUNTING OFFICER

  • Officer
19,117 2021-07-26 3

CASTELLANO THOMAS P SVP, CHIEF FINANCIAL OFFICER

  • Officer
21,020 2021-07-26 3

BARBER MICHAEL J

  • Director
0 2021-04-28 2

JOSEPH WETTENY SVP & CHIEF FINANCIAL OFFICER

  • Officer
49,823 2021-02-16 4

ZIPPELIUS PETER

  • Director
6,428 2020-11-23 3

STAHL JACK L

  • Director
30,777 2020-10-29 2

CLASSON ROLF A

  • Director
30,777 2020-10-29 2

LUCIER GREGORY T

  • Director
24,775 2020-10-29 2

CARROLL J MARTIN

  • Director
26,635 2020-10-29 2

MOREL DONALD E JR

  • Director
52,911 2020-10-29 2

BALACHANDRAN MADHAVAN

  • Director
14,897 2020-10-29 2

CRANE ROSEMARY A

  • Director
11,329 2020-10-29 2

GREISCH JOHN J

  • Director
24,329 2020-10-29 2

KREUZBURG CHRISTA

  • Director
8,765 2020-10-29 3

BUZY PETER L PRESIDENT, GENE THERAPY

  • Officer
45,950 2020-04-09 0

LITTLEJOHNS BARRY PRESIDENT, BIOLOGICS & SDD

  • Officer
45,882 2019-08-22 0

HEGWOOD PAUL W JR PRESIDENT, CSS

  • Officer
11,848 2019-08-22 0

MIYAMOTO LANCE SVP, HUMAN RESOURCES

  • Officer
46,799 2019-03-07 0

DOWNIE WILLIAM SVP, GLOBAL SALES & MARKETING

  • Officer
34,926 2019-02-15 0

ROEHRHOFF UWE

  • Director
16,489 2017-11-21 0

DOLAN CHRISTINE SVP - PRODUCT DEVELOPMENT

  • Officer
19,449 2017-08-29 0

QUELLA JAMES

  • Director
20,641 2017-08-24 0

WALSH MATTHEW M EVP & CHIEF FINANCIAL OFFICER

  • Officer
103,703 2017-08-24 0

JOHNSON SHARON SEE REMARKS

  • Officer
30,829 2017-04-25 0

BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C.

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

BLACKSTONE CAPITAL PARTNERS V L P

BMA V L.L.C.

BLACKSTONE HOLDINGS III L.P.

BLACKSTONE HOLDINGS III GP L.P.

BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
No longer subject to file 2016-09-09 0

BOOTH MELVIN D

  • Director
16,665 2016-08-24 0

LEONARD STEPHEN SEE REMARKS

  • Officer
51,741 2016-07-26 0

HOULTON SCOTT SEE REMARKS

  • Officer
0 2015-09-02 0

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

  • 10% Owner
40,030,960 2015-04-14 0

KURT NIELSEN SEE REMARKS

  • Officer
23,676 2015-02-17 0

MCEVOY BRUCE

  • Director
0 2014-07-31 0

CHU CHINH

  • Director
0 2014-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

2021-07-28 16:29:33 -0400 2021-07-26 A 5,495 a 5,495 direct

CHIMINSKI JOHN R - Director - Officer CHAIR & CEO

2021-07-28 16:25:54 -0400 2021-07-26 A 85,165 a 85,165 direct

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2021-07-28 16:26:19 -0400 2021-07-26 A 9,158 a 9,158 direct

FLYNN KAREN - Officer PRES. BIOLOGICS & CCO

2021-07-28 16:26:40 -0400 2021-07-26 A 5,953 a 5,953 direct

GENNADIOS ARISTIPPOS - Officer PRESIDENT SOFTGEL & ORAL TECH

2021-07-28 16:27:00 -0400 2021-07-26 A 885 a 51,735 direct 0.4107 0.4107 2 0.0 1

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2021-07-28 16:27:30 -0400 2021-07-26 A 974 a 17,579 direct 0.4107 0.4107 2 0.0 1

GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

2021-07-28 16:27:57 -0400 2021-07-26 A 753 a 16,183 direct 0.4107 0.4107 2 0.0 1

MASELLI ALESSANDRO - Officer PRESIDENT & COO

2021-07-28 16:28:18 -0400 2021-07-26 A 15,568 a 15,568 direct

HOPSON RICKY - Officer VP, CHIEF ACCOUNTING OFFICER

2021-07-28 16:28:53 -0400 2021-07-26 A 2,565 a 2,565 direct

PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

2021-07-28 16:28:36 -0400 2021-07-26 A 4,579 a 4,579 direct

WHITLOW RICCI S - Officer PRESIDENT, CSS

2021-07-28 16:30:03 -0400 2021-07-26 A 2,748 a 2,748 direct

ARNOLD JONATHAN - Officer PRES. ORAL & SPECIALTY DELIV.

2021-07-28 16:25:26 -0400 2021-07-26 A 4,579 a 4,579 direct

SCHMIDT KAY A - Officer SVP, TECHNICAL OPERATIONS

2021-07-28 16:29:12 -0400 2021-07-26 A 885 a 14,204 direct 0.4107 0.4107 2 0.0 1

CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

2021-07-28 16:29:33 -0400 2021-07-26 A 1,062 a 15,525 direct 0.4107 0.4107 2 0.0 1

CHIMINSKI JOHN R - Director - Officer CHAIR & CEO

2021-07-28 16:25:54 -0400 2021-07-26 A 16,461 a 168,942 direct 0.4107 0.4107 2 0.0 1

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2021-07-28 16:26:19 -0400 2021-07-26 A 1,770 a 69,133 direct 0.4107 0.4107 2 0.0 1

FLYNN KAREN - Officer PRES. BIOLOGICS & CCO

2021-07-28 16:26:40 -0400 2021-07-26 A 1,151 a 35,695 direct 0.4107 0.4107 2 0.0 1

GENNADIOS ARISTIPPOS - Officer PRESIDENT SOFTGEL & ORAL TECH

2021-07-28 16:27:00 -0400 2021-07-26 S 465 $113.05 d 50,850 direct yes 0.4107 0.4107 2 0.0 1

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2021-07-28 16:27:30 -0400 2021-07-26 S 451 $113.05 d 16,605 direct yes 0.4107 0.4107 2 0.0 1

GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

2021-07-28 16:27:57 -0400 2021-07-26 S 470 $113.02 d 15,430 direct yes 0.4107 0.4107 2 0.0 1

MASELLI ALESSANDRO - Officer PRESIDENT & COO

2021-07-28 16:28:18 -0400 2021-07-26 A 3,009 a 21,634 direct 0.4107 0.4107 2 0.0 1

HOPSON RICKY - Officer VP, CHIEF ACCOUNTING OFFICER

2021-07-28 16:28:53 -0400 2021-07-26 A 496 a 16,552 direct 0.4107 0.4107 2 0.0 1

PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

2021-07-28 16:28:36 -0400 2021-07-26 A 885 a 11,497 direct 0.4107 0.4107 2 0.0 1

WHITLOW RICCI S - Officer PRESIDENT, CSS

2021-07-28 16:30:03 -0400 2021-07-26 A 531 a 3,107 direct 0.4107 0.4107 2 0.0 1

ARNOLD JONATHAN - Officer PRES. ORAL & SPECIALTY DELIV.

2021-07-28 16:25:26 -0400 2021-07-26 A 885 a 39,367 direct 0.4107 0.4107 2 0.0 1

SCHMIDT KAY A - Officer SVP, TECHNICAL OPERATIONS

2021-07-28 16:29:12 -0400 2021-07-26 S 547 $113.05 d 13,319 direct yes 0.4107 0.4107 2 0.0 1

CASTELLANO THOMAS P - Officer SVP, CHIEF FINANCIAL OFFICER

2021-07-28 16:29:33 -0400 2021-07-26 S 555 $113.05 d 14,463 direct yes 0.4107 0.4107 2 0.0 1

CHIMINSKI JOHN R - Director - Officer CHAIR & CEO

2021-07-28 16:25:54 -0400 2021-07-26 S 11,137 $113.05 d 152,481 direct yes 0.4107 0.4107 2 0.0 1

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2021-07-28 16:26:19 -0400 2021-07-26 S 1,549 $113.05 d 67,363 direct yes 0.4107 0.4107 2 0.0 1

GENNADIOS ARISTIPPOS - Officer PRESIDENT SOFTGEL & ORAL TECH

2021-07-28 16:27:00 -0400 2021-07-26 A 4,579 a 4,579 direct

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2021-07-28 16:27:30 -0400 2021-07-26 A 5,037 a 5,037 direct

GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

2021-07-28 16:27:57 -0400 2021-07-26 A 3,892 a 3,892 direct

GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

2021-07-28 16:27:57 -0400 2021-07-26 S 609 $113.05 d 15,900 direct yes 0.4107 0.4107 2 0.0 1

MASELLI ALESSANDRO - Officer PRESIDENT & COO

2021-07-28 16:28:18 -0400 2021-07-26 S 993 $113.05 d 18,625 direct yes 0.4107 0.4107 2 0.0 1

HOPSON RICKY - Officer VP, CHIEF ACCOUNTING OFFICER

2021-07-28 16:28:53 -0400 2021-07-26 S 360 $113.05 d 16,056 direct yes 0.4107 0.4107 2 0.0 1

PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

2021-07-28 16:28:36 -0400 2021-07-26 S 458 $113.05 d 10,612 direct yes 0.4107 0.4107 2 0.0 1

SCHMIDT KAY A - Officer SVP, TECHNICAL OPERATIONS

2021-07-28 16:29:12 -0400 2021-07-26 A 4,579 a 4,579 direct

ARNOLD JONATHAN - Officer PRES. ORAL & SPECIALTY DELIV.

2021-07-28 16:25:26 -0400 2021-07-26 S 120 $113.05 d 38,482 direct yes 0.4107 0.4107 2 0.0 1

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2021-07-16 13:06:36 -0400 2021-07-15 S 1,187 $110.46 d 68,912 direct yes 1.5297 6.4945 6.4945 6 0.0 1

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2021-07-16 13:06:36 -0400 2021-07-15 S 3,313 $109.64 d 70,099 direct yes 1.5297 6.4945 6.4945 6 0.0 1

PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

2021-06-24 18:10:57 -0400 2021-06-23 S 2,800 $110.58 d 11,070 direct yes 0.4122 1.7955 1.7955 6 -0.9527 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CATALENT INC CTLT 2021-08-02 18:45:03 UTC -0.19 0.25 5900000
CATALENT INC CTLT 2021-08-02 18:15:03 UTC -0.19 0.25 5900000
CATALENT INC CTLT 2021-08-02 17:45:03 UTC -0.19 0.25 5900000
CATALENT INC CTLT 2021-08-02 17:15:03 UTC -0.19 0.25 5900000
CATALENT INC CTLT 2021-08-02 16:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 16:15:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 15:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 15:15:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 14:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 14:15:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 13:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 13:15:04 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-08-02 12:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 22:15:02 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 21:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 21:15:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 20:45:02 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 20:15:02 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 19:45:03 UTC -0.17 0.25 5900000
CATALENT INC CTLT 2021-07-30 19:15:02 UTC -0.17 0.25 5900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund CTLT -1986.0 shares, $-111811.8 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund CTLT -1742.0 shares, $-98074.6 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund CTLT -7587.0 shares, $-361596.42 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund CTLT -24803.0 shares, $-1182110.98 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund CTLT -68.0 shares, $-3532.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund CTLT -105.0 shares, $-5454.75 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund CTLT -867.0 shares, $-41321.22 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CTLT -127.0 shares, $-6597.65 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CTLT -300.0 shares, $-31593.0 2021-03-31 N-PORT
FundVantage Trust- Gotham Hedged Core Fund CTLT -709.0 shares, $-74664.79 2021-03-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund CTLT -178.0 shares, $-18745.18 2021-03-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund CTLT -37.0 shares, $-3896.47 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund CTLT -412.0 shares, $-43387.72 2021-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund CTLT -660.0 shares, $-69504.6 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund CTLT -1109.0 shares, $-116788.79 2021-03-31 N-PORT
First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF CTLT -8301.0 shares, $-933613.47 2021-04-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Large Co Value Equity Investments CTLT -15716.0 shares, $-1767578.52 2021-04-30 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND CTLT -1417.0 shares, $-159369.99 2021-04-30 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund CTLT 7593.0 shares, $-795974.19 2021-05-31 N-PORT
GMO TRUST- GMO Alternative Allocation Fund CTLT -3000.0 shares, $-314490.0 2021-05-31 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund CTLT -3400.0 shares, $-356422.0 2021-05-31 N-PORT
GMO TRUST- GMO Implementation Fund CTLT -51500.0 shares, $-5398745.0 2021-05-31 N-PORT
GMO TRUST- GMO Benchmark-Free Fund CTLT -19500.0 shares, $-2044185.0 2021-05-31 N-PORT

Elevate your investments